Synthetic Somatostatin Analog (Octreotide) Suppresses Daytime Growth Hormone Secretion Equivalently in Young and Older Men: Preserved Pituitary Responsiveness to Somatostatin's Inhibition in Aging
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
OBJECTIVE : To gain greater insight into the mechanisms controlling the low daytime rate of growth hormone (GH) secretion in older men. DESIGN : We conducted a randomized, controlled study of GH secretion during inhibition by octreotide, a somatostatin analog. PARTICIPANTS : Nine young (35–44 years) and ten older (62–79 years) healthy men participated. INTERVENTION : Octreotide versus nothing, while subjects were on a standardized diet. MEASUREMENTS : All subjects were assessed on two separate occasions: baseline and at time of the intervention of octreotide (100 μg subcutaneously); the order of the intervention was randomly assigned. Octreotide was administered at 8:00 a.m. Venous sampling was performed every 10 minutes for 8 hours (8:30 a.m. to 4:30 p.m.). To estimate the joint parameters of pulsatile and basal (between secretory pulses) GH secretion, we used an ultrasensitive chemiluminescence‐based GH assay and multiparameter deconvolution analysis. RESULTS : Compared with baseline, octreotide markedly reduced mean (8‐hour) serum GH concentrations in both young (0.585 ± 0.255 μg/L vs 0.070 ± 0.029 μg/L; P = .008) and older (0.397 ± 0.107 μg/L vs 0.087 ± 0.027 μg/L; P = 0.005) men. In younger men, octreotide decreased the serum GH concentration primarily by suppressing the mass of GH released per secretory pulse (2.4 ± 0.9 μg/L vs 1.0 ± .7 μg/L; P = .015) and the interpulse (basal) rate of GH release (0.0014 ± 0.0003 μg/L/min vs 0.0006 ± 0.0002 μg/L/min; P = .051). In older men, octreotide also restrained the mass of GH per secretory pulse (1.5 ± 0.4 μg/L vs 0.4 ± 0.1 μg/L; P = .028) and lowered basal GH release (0.0014 ± 0.0003 μg/L/min vs 0.0004 ± 0.0001 μg/L/min; P = .007). There were no significant differences when the older men were compared with the young controls. CONCLUSIONS : Our data suggest that the daytime relative GH deficiency seen in older men is not a result of excessive pituitary susceptibility to the inhibitory capabilities of somatostatin, but more likely reflects impoverished endogenous GHRH drive and/or heightened release of brain somatostatin. J Am Geriatr Soc 47:1422–1424, 1999.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Giustina, A., & Veldhuis, J. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0353 · Cited by 1,253
Self-citationFrohman, L. A., Downs, T. R., Clarke, I. J., & Thomas, G. B. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114681 · Cited by 178
Cited by
Hormone Replacement Therapy and Physical Function in Healthy Older Men. Time to Talk Hormones?
Giannoulis, M. G., Martin, F. C., Nair, K. S., Umpleby, A. M., & Sonksen, P. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1002 · Cited by 132
Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men.
Gentili, A., Mulligan, T., Godschalk, M., Clore, J., Patrie, J., Iranmanesh, A., & Veldhuis, J. D. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8222 · Cited by 98
Self-citationErickson, D., Keenan, D. M., Mielke, K., Bradford, K., Bowers, C. Y., Miles, J. M., & Veldhuis, J. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0424 · Cited by 26
Self-citationRichmond, E., Rogol, A. D., Basdemir, D., Veldhuis, O. L., Clarke, W., Bowers, C. Y., & Veldhuis, J. D. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8770 · Cited by 19
Self-citationIranmanesh, A., Bowers, C. Y., & Veldhuis, J. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0205 · Cited by 10
Self-citation
Metadata
- Authors
- Mulligan, T., Jaen‐Vinuales, A., Godschalk, M., Iranmanesh, A., & Veldhuis, J. D.
- Venue
- Journal of the American Geriatrics Society
- Publisher
- Wiley
- Published
- 1999-12
- Volume
- 47
- Issue
- 12
- Pages
- 1422-1424
- ISSN
- 0002-8614 (ISSN-L)
- 1532-5415
- OpenAlex
- W2024959979
- Cited by
- 22
- References
- 2
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Synthetic Somatostatin Analog (Octreotide) Suppresses Daytime Growth Hormone Secretion Equivalently in Young and Older Men: Preserved Pituitary Responsiveness to Somatostatin's Inhibition in Aging. https://app.cochat.ai/papers/10.1111/j.1532-5415.1999.tb01560.x
- The paper
- Mulligan, T., Jaen‐Vinuales, A., Godschalk, M., Iranmanesh, A., & Veldhuis, J. D. (1999). Synthetic Somatostatin Analog (Octreotide) Suppresses Daytime Growth Hormone Secretion Equivalently in Young and Older Men: Preserved Pituitary Responsiveness to Somatostatin's Inhibition in Aging. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.1999.tb01560.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.